With 60% Ownership of the Shares, Gossamer Bio, Inc. (NASDAQ:GOSS) Is Heavily Dominated by Institutional Owners

Yahoo FinanceMar 3 05:04 ET

Is Gossamer Bio (NASDAQ:GOSS) Weighed On By Its Debt Load?

Simply Wall StFeb 6 05:01 ET

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

BusinesswireFeb 3 07:01 ET

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Yahoo FinanceJan 30 08:08 ET

Gossamer Bio's Strategic Focus on PAH Unmet Needs and Seralutinib Efficacy Drives Buy Rating

TipRanksJan 27 01:15 ET · Ratings

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireJan 7 17:30 ET